Navigation Links
Labopharm in Medical News

Labopharm Reports Results for Second Quarter Fiscal 2009

...- LAVAL, QC, Aug. 7 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today reported it...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "We are encouraged by a number of aspects sin...hat RYZOLT was just recently launched in May 2009, labopharm is recording its royalty earned for the quarter ba...

Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference

... LAVAL, QC, July 30 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...entation will be available for 30 days. About labopharm Inc. labopharm is an emerging leader in optimizing the performanc...

Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)

...- LAVAL, QC, July 27 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...discuss its second quarter 2009 financial results. labopharm will report its second quarter 2009 financial resu...ived at the above web site for 30 days. About labopharm Inc. ...

Labopharm receives complete response letter from the U.S. FDA for novel antidepressant

... LAVAL, QC, July 20 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced i...ed. The API manufacturer, Angelini, has informed labopharm that, further to the FDA's complete response lette...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "We continue to prepare for the commercializa...

Labopharm amends debt facility agreement with Hercules

...- LAVAL, QC, June 25 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced i...able repayment terms. Under the amended agreement, labopharm has extended the date required to begin repaying t.... In consideration of the revised repayment terms, labopharm will not draw down the remaining US$5 million of t...

Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal

...- LAVAL, QC, May 19 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...dy to Appear at Scientific Meeting in Florida labopharm will present a poster discussing the results of th... User Fee Act (PDUFA) is July 18, 2009. About labopharm Inc. ...

New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.

...December 31, 2010(1). RYZOLT was developed by labopharm Inc. (Nasdaq: DDSS ; TSX: DDS) of Canada and app... be found at www.purduepharma.com . About labopharm Inc. labopharm is an emerging leader in optimizing the performanc...

Labopharm Reports Results for First Quarter Fiscal 2009

.... - LAVAL, QC, May 7 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today reported it...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "With Ryzolt(TM), U.S. physicians now have a ...ing Partnerships for Eleven Additional Countries - labopharm signed an agreement with iNova Pharmaceuticals, it...

Labopharm announces details for first quarter results conference call and annual meeting

... LAVAL, QC, April 23 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...nce Call On Thursday, May 7 at 8:30 a.m. (ET) labopharm will host a conference call to discuss its first quarter 2009 financial results. labopharm will report its first quarter 2009 financial resul...

Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation

... LAVAL, QC, April 2 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t... and demonstration of efficacy in clinical trials. labopharm believes that it is likely that the results of thi...o severe pain in the rest of the world. About labopharm Inc. ...
Labopharm in Medical Technology

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... LAVAL, QC, Aug. 5 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced i...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "We believe the $800 million-plus Canadian ma...depression at some time in their lives. About labopharm Inc. ...

Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline

...lowing are the top five drugs in each category of phase changes: The Five Most Promising Drugs Entering Phase III Trials - trazodone, (Depression), labopharm - pimavanserin, (Schizophrenia), ACADIA Pharmaceuticals - salmon calcitonin, (Osteoporosis/Paget's disease), Novartis/Nordic Bioscience - Generx...

Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine

... LAVAL, QC, June 29, 2007 /PRNewswire-FirstCall/ - labopharm Inc. today announced that it will present a poster...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "The ability to quickly titrate patients to t...s of Labopharm's drug optimization technologies. labopharm also announced today that an article discussing th...
Other Tags
(Date:9/30/2014)... By Kathleen Doheny ... (HealthDay News) -- Children who are given broad-spectrum antibiotics ... higher risk of becoming obese during childhood, new research ... organisms than narrow-spectrum ones, according to the study. ... need antibiotics, and which antibiotic you are picking," said ...
(Date:9/30/2014)... VA (PRWEB) September 30, 2014 Visit ... of Chestnut Hill and you will find a loving ... together, Amyotrophic Lateral Sclerosis. , Steve was ... or Lou Gehrig’s Disease – just before the couple’s ... primary caregiver. , A new video, “Care, Support ...
(Date:9/30/2014)... September 30, 2014 TrailMyx.com —the ... October Flavor of the Month: raw pumpkin seeds. , ... of squash”)—are rich in protein, and valued by experts ... multiple types of vitamin E. They are prized for ... and proper bowel function. , Of course, pumpkin seeds ...
(Date:9/30/2014)... 30, 2014 Thanks to ... National Children’s Oral Health Foundation: America’s ToothFairy® ... to non-profit clinical partners. These organizations are ... deliver comprehensive educational, preventive and treatment services ...     Just Kids Dental: $25,000 ...
(Date:9/30/2014)... 30, 2014 (HealthDay News) -- In books and movies, plots ... Now, new research suggests that the stereotype may ... looked at data on more than 12,000 people from Finland. ... in Turku, Finland, found that women typically preferred men who ... consistent throughout their lives. On the other hand, men ...
Breaking Medicine News(10 mins):Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:TrailMyx.com Features October Flavor of the Month 2Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 2Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 3Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2
(Date:9/29/2014)... . Montreal, ... expectant mother was deprived of electricity during Quebec,s Ice ... a new study finds., Scientists from the Douglas Mental ... distinctive ,signature, in the DNA of children born in ... months after the event, researchers recruited women who had ...
(Date:9/29/2014)... Sclerosis (MS) were able to safely tolerate treatment with ... study published today in the journal Multiple Sclerosis ... first of its kind, was conducted by researchers at ... and collaborators at several other institutions. , While ... in the data also suggested that a preparation of ...
(Date:9/27/2014)... The first direct comparison of treating non-squamous lung ... to cisplatin has shown that the two combinations ... with more frequent adverse events. , At the ... from Chonnam National University Medical School, South Korea, ... trial that included 149 patients with non-squamous non-small ...
Breaking Biology News(10 mins):Cells from placentas safe for patients with multiple sclerosis 2Docetaxel or pemetrexed with cisplatin achieve comparable outcomes in non-squamous Lu Ca 2
Other Contents